Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI in Pediatric and Neonatal Patient Population (<18years)
Latest Information Update: 23 May 2022
At a glance
- Drugs Gadoterate-meglumine (Primary)
 - Indications CNS disorders
 - Focus Diagnostic use
 
Most Recent Events
- 18 May 2022 Status changed from recruiting to completed.
 - 13 Mar 2017 Planned End Date changed from 1 Jan 2018 to 8 Feb 2018.
 - 13 Mar 2017 Planned primary completion date changed from 1 Jan 2018 to 8 Feb 2018.